Keros Therapeutics Inc

-0.53 (-1.26%)
4:01:53 PM EDT: $41.44 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.18B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.33 Million
Adjusted EPS-$1.12
See more estimates
10-Day MA$43.91
50-Day MA$51.82
200-Day MA$42.65
See more pivots

Keros Therapeutics Inc Stock, NASDAQ:KROS

1050 Waltham Street, Suite 302, Lexington, Massachusetts 02421
United States of America
Phone: +1.617.314.6297
Number of Employees: 105


Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.